{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:21:57Z","timestamp":1789932117348,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Fondation pour la recherche m\u00e9dicale","doi-asserted-by":"publisher","award":["FRM FDM20150633674"],"award-info":[{"award-number":["FRM FDM20150633674"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.revmed.2016.08.019","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T18:22:22Z","timestamp":1474309342000},"page":"265-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Le d\u00e9ficit en m\u00e9valonate kinase en 2016"],"prefix":"10.1016","volume":"39","author":[{"given":"C.","family":"Galeotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sarrabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kon\u00e9-Paut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.08.019_bib0005","first-page":"163","article-title":"Nosologic aspects of systemic forms of very-early-onset juvenile arthritis. Apropos of 17 cases","volume":"60","author":"Prieur","year":"1984","journal-title":"Sem Hop"},{"key":"10.1016\/j.revmed.2016.08.019_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.ejhg.5201323","article-title":"MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever","volume":"13","author":"D\u2019Osualdo","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0020","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/ard.2006.054494","article-title":"Hyperimmunoglobulinaemia D syndrome in India: report of two siblings with a novel mutation","volume":"65","author":"Lawrence","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13312-012-0099-0","article-title":"Novel mutations causing hyperimmunoglobulin D and periodic fever syndrome","volume":"49","author":"Sinha","year":"2012","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.revmed.2016.08.019_bib0030","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.revmed.2016.08.019_bib0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.157.1.400","article-title":"Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells","volume":"157","author":"Drenth","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2016.08.019_bib0040","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.10550","article-title":"Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome","volume":"46","author":"Frenkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.08.019_bib0045","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","article-title":"HMG-CoA reductase inhibition induces IL-1beta release through Rac1\/PI3K\/PKB-dependent caspase-1 activation","volume":"112","author":"Kuijk","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.08.019_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ejhg.2010.9","article-title":"The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency","volume":"18","author":"Pontillo","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0055","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0060","first-page":"260","article-title":"Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model","volume":"63","author":"Bodar","year":"2005","journal-title":"Neth J Med"},{"key":"10.1016\/j.revmed.2016.08.019_bib0065","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/rheumatology\/kes097","article-title":"Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency","volume":"51","author":"Galeotti","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2016.08.019_bib0070","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0075","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","article-title":"A role for geranylgeranylation in interleukin-1beta secretion","volume":"54","author":"Mandey","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.08.019_bib0080","doi-asserted-by":"crossref","first-page":"27757","DOI":"10.1074\/jbc.M114.571810","article-title":"Unprenylated RhoA contributes to IL-1beta hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity","volume":"289","author":"van der Burgh","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2016.08.019_bib0085","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1074\/jbc.M113.536920","article-title":"Defects in mitochondrial clearance predispose human monocytes to interleukin-1beta hypersecretion","volume":"289","author":"van der Burgh","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2016.08.019_bib0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/rheumatology\/keu341","article-title":"TLR2\/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"54","author":"Stoffels","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2016.08.019_bib0095","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/hmg\/11.25.3115","article-title":"Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome","volume":"11","author":"Houten","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1010577207726","article-title":"Mevalonic aciduria and hyper-IgD syndrome: two sides of the same coin?","volume":"24","author":"Tsimaratos","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2016.08.019_bib0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jbspin.2014.12.011","article-title":"A restrospective survey of patients's journey before the diagnosis of mevalonate kinase deficiency","volume":"82","author":"Berody","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2016.08.019_bib0115","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2011-200549","article-title":"An international registry on autoinflammatory diseases: the Eurofever experience","volume":"71","author":"Toplak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0120","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3899\/jrheum.081313","article-title":"A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever","volume":"36","author":"Steichen","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2016.08.019_bib0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF00918854","article-title":"Immunological studies in the hyper-immunoglobulin D syndrome","volume":"12","author":"Haraldsson","year":"1992","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2016.08.019_bib0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/01.WNL.0000115390.33405.F7","article-title":"Mevalonate kinase deficiency: evidence for a phenotypic continuum","volume":"62","author":"Simon","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.08.019_bib0135","first-page":"33","article-title":"Diagnostic value of urinary mevalonic acid excretion in patients with a clinical suspicion of mevalonate kinase deficiency (MKD)","volume":"27","author":"Jeyaratnam","year":"2016","journal-title":"JIMD Rep"},{"key":"10.1016\/j.revmed.2016.08.019_bib0140","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/ng.2409","article-title":"Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0145","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.ophtha.2013.07.052","article-title":"Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa","volume":"120","author":"Siemiatkowska","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2016.08.019_bib0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.ejhg.5200933","article-title":"Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands","volume":"11","author":"Houten","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ejhg.5200595","article-title":"Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"9","author":"Houten","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.revmed.2016.08.019_bib0165","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/annrheumdis-2011-201271","article-title":"Guidelines for the genetic diagnosis of hereditary recurrent fevers","volume":"71","author":"Shinar","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.22409","article-title":"First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome","volume":"56","author":"Rigante","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.08.019_bib0175","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/acr.22527","article-title":"11-month-old infant with periodic fevers, recurrent liver dysfunction, and perforin gene polymorphism","volume":"67","author":"Schulert","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.revmed.2016.08.019_bib0180","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1053\/j.ajkd.2006.05.027","article-title":"Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease?","volume":"48","author":"Siewert","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0185","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.21901","article-title":"AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases","volume":"54","author":"Lachmann","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.08.019_bib0190","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","article-title":"AA amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.08.019_bib0195","first-page":"865","article-title":"Renal amyloidosis due to hyper-IgD syndrome","volume":"32","author":"Li Cavoli","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.revmed.2016.08.019_bib0200","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/art.20490","article-title":"First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome","volume":"50","author":"Obici","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.08.019_bib0205","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF02238553","article-title":"Atypical hypergammaglobulinaemia D syndrome with amyloidosis: an overlap with familial Mediterranean fever?","volume":"15","author":"Ostuni","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2016.08.019_bib0210","first-page":"70","article-title":"Amyloidosis in a child with hyperimmunoglobulinemia D syndrome","volume":"7","author":"Yel","year":"2013","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0215","first-page":"43","article-title":"Amyloid A amyloidosis secondary to hyper-IgD syndrome and response to IL-1 blockage therapy","volume":"74","author":"Kallianidis","year":"2016","journal-title":"Neth J Med"},{"key":"10.1016\/j.revmed.2016.08.019_bib0220","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-006-0408-7","article-title":"Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis","volume":"29","author":"Cailliez","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0225","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1542\/peds.2006-2015","article-title":"Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency","volume":"119","author":"Nevyjel","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.revmed.2016.08.019_bib0230","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/rheumatology\/kem258","article-title":"Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra","volume":"46","author":"Lequerre","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2016.08.019_bib0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","article-title":"Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome","volume":"27","author":"Rigante","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2016.08.019_bib0240","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","article-title":"Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"48","author":"Takada","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.08.019_bib0245","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10067-008-0911-3","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up","volume":"27","author":"Topaloglu","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2016.08.019_bib0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.RHU.0000442576.41537.de","article-title":"Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome","volume":"20","author":"Shendi","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.revmed.2016.08.019_bib0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1750-1172-8-196","article-title":"Weekly oral alendronate in mevalonate kinase deficiency","volume":"8","author":"Cantarini","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2016.08.019_bib0260","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1056\/NEJMoa070715","article-title":"Allogeneic bone marrow transplantation in mevalonic aciduria","volume":"356","author":"Neven","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.08.019_bib0265","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMc072018","article-title":"Mevalonic aciduria cured by bone marrow transplantation","volume":"357","author":"Arkwright","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.08.019_bib0270","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1600-6143.2011.03989.x","article-title":"Liver transplantation followed by allogeneic hematopoietic stem cell transplantation for atypical mevalonic aciduria","volume":"12","author":"Chaudhury","year":"2012","journal-title":"Am J Transplant"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316305331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316305331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:39:28Z","timestamp":1759336768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316305331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0248866316305331"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.08.019","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le d\u00e9ficit en m\u00e9valonate kinase en 2016","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}